Shandong Boan Biotechnology Co Ltd Sustainability Reports
The company develops, manufactures, and commercializes biopharmaceutical products, specializing in therapeutic antibodies, biosimilars, and novel biologics for oncology, metabolism, autoimmunity, and ophthalmology.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
LEI: 655600B3N9CTYRC9VW56
FIGI: BBG017GWL350
8 reports from 2022 to 2025
- Shandong Boan Biotechnology Co Ltd 2025 Environmental, Social and Governance Report
- Shandong Boan Biotechnology Co Ltd 2025 Annual Report
- Shandong Boan Biotechnology Co Ltd 2024 Annual Report
- Shandong Boan Biotechnology Co Ltd 2024 Environmental, Social and Governance Report
- Shandong Boan Biotechnology Co Ltd 2023 Annual Report